Back to User profile » Dr Wei Jiang

Papers published by Dr Wei Jiang:

Original Research

Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy

Yuan C, Huang M, Wang H, Jiang W, Su C, Zhou S

Cancer Management and Research 2022, 14:377-386

Published Date: 26 January 2022

Original Research

Comparison of Different EGFR Gene Mutation Status in Patients with Metastatic Non-Small Lung Cancer After First-Line EGFR-TKIs Therapy and Analyzing Its Relationship with Efficacy and Prognosis

Yuan C, Jiang H, Jiang W, Wang H, Su C, Zhou S

Cancer Management and Research 2021, 13:6901-6910

Published Date: 3 September 2021

Original Research

Prognostic Value of Pretreatment Albumin-to-Alkaline Phosphatase Ratio in Extensive-Disease Small-Cell Lung Cancer: A Retrospective Cohort Study

Zhou S, Wang H, Jiang W, Yu Q, Zeng A

Cancer Management and Research 2020, 12:2015-2024

Published Date: 18 March 2020

Original Research

Clinicopathological Characteristics And EGFR-TKIs Efficacies In Lung Squamous Cell Carcinoma Patients Harboring An EGFR Sensitizing Mutation

Zhou S, Wang H, Jiang W, Yu Q

OncoTargets and Therapy 2019, 12:8863-8871

Published Date: 30 October 2019

Original Research

Efficacy of bevacizumab versus epidermal growth factor receptor inhibitors for wild-type RAS metastatic colorectal cancer: a meta-analysis

Jiang W, Yu Q, Ning R, Zhao W, Wei C

OncoTargets and Therapy 2018, 11:4271-4281

Published Date: 24 July 2018